We are live on ! Find out more
ACLX

Arcellx
ACLX

Delisted

ACLX was delisted on the 27th of April, 2026.

Back to rankings

2 hedge funds and large institutions have $3.43M invested in Arcellx in 2026 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 234 closing their positions.

New
Increased
Maintained
Reduced
Closed

97.44% less ownership

Funds ownership: 97.49% → 0.05% (-97%)

99% less funds holding

Funds holding: 240 → 2 (-238)

100% less capital invested

Capital invested by funds: $6.52B → $3.43M (-$6.51B)

100% less funds holding in top 10

Funds holding in top 10: 22 → 0 (-22)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 234

Holders
2
Holders Change
-238
Holders Change %
-99.17%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-22
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
234
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IA
IFP Advisors
Florida
+$115

Top Sellers

Rank Fund Capital Flow
1
GS
Gilead Sciences
California
-$772M
2
PBA
Paradigm Biocapital Advisors
New York
-$663M
3
BlackRock
BlackRock
New York
-$453M
4
NMC
NEA Management Company
Maryland
-$350M
5
PCM
Pentwater Capital Management
Florida
-$330M

ACLX Hedge Fund Activity: Q2 2026 in Review

2 of the 8,323 institutional investors tracked by Wall St. Rank reported a position in Arcellx (ACLX) for Q2 2026, worth a combined $3.43M — down 100% from $6.52B a quarter earlier.

Sellers outnumbered buyers: 234 funds closed out of ACLX and 0 opened new positions — a net loss of 234 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was IFP Advisors, adding an estimated $115. The largest seller was Gilead Sciences, exiting entirely with an estimated $772M sold.

  • 2 institutional investors held Arcellx (ACLX) as of Q2 2026, down from 240 in Q1 2026.
  • Funds reported $3.43M of Arcellx stock for Q2 2026, down 100% quarter-over-quarter.
  • 0 funds opened new Arcellx positions in Q2 2026 and 234 closed out, a net change of -234 holders.
  • The largest Arcellx buyer in Q2 2026 was IFP Advisors, an estimated $115 added.
  • The largest Arcellx seller in Q2 2026 was Gilead Sciences, an estimated $772M sold.

Based on aggregated 13F filings for Q2 2026.